Q2 FY2026 EarningsAVAH Q2 FY26 exceeded consensus across all top and bottom-line metrics: revenue $670.5M vs. $638.6M expected, and normalized EPS $0.22 vs. $0.17 expected. The revenue beat was primarily driven by the PDS segment, which grew 14% YoY, while operating cash flow of $85.3M significantly outpaced expectations. Management raised FY26 revenue guidance to >$2.68B and Adjusted EBITDA to >$365M, reflecting sustained organic growth momentum.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Aveanna Healthcare(AVAH) the Revenue is 670.48 M (+13.73%), Beat estimate;the EBIT is 92.59 M (+7.96%), Beat estimate;the EPS is 0.18 (+38.46%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.67B13.73%
0.64B8.32%
+0.03B5.41%
EBITExceed expectations
0.09B7.96%
0.08B8.60%
+0.01B16.56%
EPSExceed expectations
0.1838.46%
0.153418.03%
+0.026620.43%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf